Systemic therapy with the tyrosine kinase inhibitor lenvatinib in six patients with distantly metastatic malignant melanoma

被引：0
|
作者：
Klumpp, A. [1 ]
Stege, H. [1 ]
Lang, B. [1 ]
Grabbe, S. [1 ]
机构：
[1] Univ Mainz Mainz, Hautklin, Mainz, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP076
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [21] Salvage lenvatinib/everolimus (LE) combination therapy after immune checkpoint inhibitor (ICI) and VEGFR tyrosine kinase inhibitor (TKI) for metastatic renal cell carcinoma (mRCC)
    Khorasanchi, Adam
    Kwok, Christopher
    Psutka, Sarah P.
    Hinkley, Megan
    Dason, Shawn
    Yang, Yuanquan
    Verschraegen, Claire F.
    Gross, Evan
    Orcutt, Delaney
    Yin, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Systemic therapy for metastatic malignant melanoma - from deeply disappointing to bright future?
    Lorigan, Paul
    Eisen, Tim
    Hauschild, Axel
    EXPERIMENTAL DERMATOLOGY, 2008, 17 (05) : 383 - 394
  • [23] Systemic treatment of distant metastatic malignant melanoma
    Dabrowski, E.
    Dippel, E.
    RADIOLOGE, 2015, 55 (02): : 99 - +
  • [24] Combination therapy with lenvatinib and radiation significantly inhibits thyroid cancer growth by uptake of tyrosine kinase inhibitor
    Suzuki, Kensuke
    Iwai, Hiroshi
    Utsunomiya, Keita
    Kono, Yumiko
    Kobayashi, Yoshiki
    Van Bui, Dan
    Sawada, Shunsuke
    Yun, Yasutaka
    Mitani, Akitoshi
    Kondo, Naoyuki
    Katano, Tayo
    Tanigawa, Noboru
    Akama, Tomoya
    Kanda, Akira
    EXPERIMENTAL CELL RESEARCH, 2021, 398 (01)
  • [25] Therapy of metastatic malignant uveal melanoma
    Jäckel, A
    Bock, M
    Deichmann, M
    Waldmann, V
    Näher, H
    HAUTARZT, 2001, 52 (02): : 98 - 103
  • [26] LINES OF SYSTEMIC THERAPY IN PATIENTS WITH METASTATIC MELANOMA IN THE UNITED STATES
    Zhao, Z.
    Wang, S.
    Barber, B.
    Wagner, V
    VALUE IN HEALTH, 2012, 15 (04) : A234 - A234
  • [27] Lines of systemic therapy in patients with metastatic melanoma in the United States
    Zhao, Zhongyun
    Wang, Song
    Barber, Beth
    Wagner, Volker Jean
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Predicting the response of CML patients to tyrosine kinase inhibitor therapy
    White D.L.
    Hughes T.P.
    Current Hematologic Malignancy Reports, 2009, 4 (2) : 59 - 65
  • [29] Predicting the Response of CML Patients to Tyrosine Kinase Inhibitor Therapy
    White, Deborah L.
    Hughes, Timothy P.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (02) : 88 - 95
  • [30] Predicting the Response of CML Patients to Tyrosine Kinase Inhibitor Therapy
    Deborah L. White
    Timothy P. Hughes
    Current Hematologic Malignancy Reports, 2011, 6
12345